微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 70.05% | -3.18% | -1.2% | 23/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 70.9% | -2.87% | 0.07% | 20/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 70.85% | -4.32% | -1.54% | 20/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 71.96% | 1.2% | -0.54% | 20/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 72.35% | 2.56% | -0.89% | 20/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 73% | 6.86% | -1.42% | 19/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 74.05% | 17.31% | 4.14% | 21/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 71.11% | 3.73% | 0.8% | 23/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 70.54% | 5.37% | 3.26% | 25/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 68.31% | 8.71% | 8.22% | 32/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 63.12% | -13.69% | -7.92% | 47/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 68.55% | -6% | 2.4% | 32/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 66.95% | 2% | 6.54% | 37/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 62.84% | -15.34% | -14.08% | 49/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 73.13% | 2% | 0.28% | 24/132 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 72.93% | -4.26% | -1.74% | 27/132 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 74.22% | 2% | -2.56% | 26/132 | 58.42% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 76.17% | 2% | 2% | 25/132 | 59.59% | 正海生物 | 90.78% | 行业排名> |